CONTRAST-ENHANCED COMPUTED TOMOGRAPHY IS THE REQUIRED MINIMUM IN THE DIAGNOSIS OF ABDOMINAL AND RETROPERITONEAL SPACE-OCCUPYING LESIONS

Objective: to determine the advantages of contrast-enhanced computed tomography (CT) over contrast-free studies in the differential diagnosis of hepatic, renal, and pancreatic space-occupying lesions. Material and methods. A team of experienced radiologists retrospectively used CT data of patients with different spaceoccupying lesions of the abdomen and retroperitoneal space (liver, kidney, and pancreas). Results. The diagnostic value of CT of the liver, kidney, and pancreas substantially decreases without using radiopaque contrast agents; at the same time not only the differential diagnosis, but also visualization of some neoplasms are frequently impossible. Conclusion. The potential benefit of contrast-enhanced CT virtually always outweighs the risks associated with the injection of a contrast agent.

1. Tyurin I.E. Radiology in the Russian Federation in 2014. Vestnik rentgenologii i radiologii. 2015; 6: 56–63 (in Russian).

2. Stern S.H. Nationwide evaluation of X-ray trends. Tabulation and graphical summary of 2000 survey of computed tomography. August 2007; 174. Available at: http:// www.crcpd.org/Pubs/NEXT_ docs/NEXT2000-CT.

3. ACR Committee on Drugs and Contrast Media. ACR Manual on Contrast Media – Version 10.1, 2015; 129. Available at: http:// www.acr.org/~/media/37D84428B F1D4E1B9A3A2918DA9E27A3.

4. Eskandari N., Nekourad M., Bastan R. The awareness of anaphylaxis reaction to local anesthesia in Dentistry. J. Allergy Asthma. 2014; 1: 1–5.

5. McDonald R.J., McDonald J.S., Carter R.E. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. Radiology. 2014; 273 (3): 714–25.

6. Navarro A.P., Gomez D., Lamb C.M. Focal nodular hyperplasia: A review of current indications for and outcomes of hepatic resection. HPB. 2014; 16: 503–11.

7. Baranes L., Chiaradia M., Pigneur F. Imaging benign hepatocellular tumors: Atypical forms and diagnostic traps. Diagn. Intervent. Imag. 2013; 94: 677–95.

8. Bosman F.T., Carneiro F., Hruban R.H., Theise N.D. WHO Classification of Tumours of the Digestive System (IARC WHO Classification of Tumours). 4th ed. 2010: 417.

9. Haoran Sun, Tianqiang Song. Hepatocellular carcinoma: Advances in diagnostic imaging. Drug Discoveries & Therapeutics. 2015; 9 (5): 310–8.

10. Tumanova U.N., Yashina N.I., Karmazanovskiy G.G. Diagnostic CT criteria for hepatocellular carcinoma of different histologic grades in non-cirrhotic liver. Diagnosticheskaya i interventsionnaya radiologiya. 2015; 9 (1): 27–33 (in Russian).

11. Bajenaru N., Balaban V., Savulescu F. Hepatic hemangioma. J. Med. Life. 2015; 8, Special Issue: 4–11.

12. Huan-Yu Wang, Liang Zhang, Jian Wu. Adult hepatic cavernous hemangioma with highly elevated A-fetoprotein: A case report and review of the literature. Oncology Letters. 2015; 9: 637–40.

13. Xingmao Zhang, Zhixiang Zhou. Hepatic hemangioma masquerading as a tumor originating from the stomach. Oncology Letters. 2015; 9: 1406–8.

14. Zakharova O.P., Kubyshkin V.A., Karmazanovskiy G.G. The requirement for the CT-scan protocol for the proper assessment of pancreatic tumors resectability. Khirurgiya. 2012; 8: 44–50 (in Russian).

15. Kuzavleva E.I. Neuroendocrine pancreatic tumors – surgigal treatment and clinical and morphological prognostic factors. MD, PhD. sci. Diss. Moscow; 2015 (in Russian).

16. Zakharova O.P., Karmazanovskiy G.G. The possibilities of MDCT and other diagnostic modalities in pancreatic cancer staging and evaluation of the tumor extent: what do diagnostic mistakes affect on? Meditsinskaya vizualizatsiya. 2012; 6: 51–6 (in Russian).

17. Makeeva-Malinovskaya N.Yu. Contrast enhancement of solid tumors as a criterion for differential diagnosis of neuroendocrine pancreatic tumors using multislice computed tomography. MD, PhD. sci. Diss. Moscow; 2014 (in Russian).

18. Eble J.N., Sauter G., Epstein J.I. et al. WHO Classification of Tumours. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC Press; 2004: 354.

19. Young J.R., Margolis D., Sauk S. et al. Clear cell renal carcinoma: Discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology. 2013; 267 (2): 444–53.

20. An Ren, Feng Cai, Yan-Ning Shang et al. Differentiation of renal oncocytoma and renal clear cell carcinoma using relative CT enhancement ratio. Chinese Med. J. 2015; 128, Is. 2: 175–9.

21.